Established Sell-Side M&A Leadership
- Activity was strong across multiple segments of healthcare services, including multi-site healthcare, pharmaceutical services, outsourced medical manufacturing, and other specialty provider groups
- 2021 was a record year for sell-side M&A activity and our pipeline points to continued robust activity in 2022
Trusted Buy-Side Advice to Clients
- Our deep insight across healthcare services provides invaluable, strategic perspectives and buy-side intelligence to our clients
- Clients value our thoughtful, post-deal M&A road mappings
- Drawing on multiple decades of transaction structuring and execution experience, we guide buyers to optimize price and terms
Continued Momentum in Equity and Debt Capital Markets
- We served as a bookrunner on 21 of 2021’s successful healthcare services equity offerings
- Our transaction scope in 2021 has included IPO’s, follow-on equity offerings, convertible debt, and private equity placements
Learn more about our healthcare services investment banking expertise.